Search

Search Constraints

You searched for: Author/Creator Stein, Anthony

Search Results

11. Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation. Issue 5 (16th April 2022)

12. Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351). Issue 6 (8th April 2021)

13. Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents. Issue 5 (18th February 2021)

16. Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With Cancer. Issue 5 (22nd March 2019)

17. Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia. (21st December 2021)

18. Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors. Issue 1 (2nd January 2023)